BioSpace News Archive

Drug Development

Rigel Announces Publication of Data from Phase 2 Clinical Study of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia in the American Journal of Hematology

Rigel Pharmaceuticals, Inc. announced the publication of data in the American Journal of Hematology from the open label, multicenter, Phase 2 clinical study of fostamatinib in adults with warm antibody autoimmune hemolytic anemia who had failed at least one prior treatment.

March 8, 2022
·
10 min read
Genetown

Cognito Therapeutics and Aetion Announce Partnership to Use Artificial Intelligence to Identify Rapidly Progressing Forms of Mild Cognitive Impairment and Alzheimer’s Disease

Cognito Therapeutics and Aetion announced a strategic partnership to develop a validated predictive model to identify patients with rapidly progressing mild cognitive impairment and Alzheimer’s disease.

March 8, 2022
·
4 min read
Biotech Bay

The Broad Institute Selects Fabric Genomics in Implementation of Clinical Whole Genome Sequencing Offering

Fabric Genomics, Inc., announced that the Broad Institute of MIT and Harvard has selected the company to support the development and implementation of its clinical whole genome sequencing-based offerings.

March 8, 2022
·
3 min read
Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles

Australian clinical-stage drug development company Noxopharm has announced its Phase 1 CEP-2 sarcoma trial is underway with a first patient enrolled and dosed at City of Hope in Los Angeles, California.

March 8, 2022
·
2 min read
Business

The Laurel Amtower Cancer Institute and Neuro-Oncology Center at Sharp HealthCare to Join Innovative Antibody Brain Cancer Drug Trial

Sharp HealthCare, in collaboration with Nascent Biotech, Inc, announced today, its participation in a clinical trial for a novel investigational immunotherapy treatment for patients with glioblastoma (GBM), the deadliest form of brain cancer.

March 8, 2022
·
4 min read
Getinge awarded a contract with Premier, Inc for Flow Family Anesthesia machines

Getinge is pleased to announce that it has been awarded a new Anesthesia contract from Premier, Inc. a leading healthcare improvement company in the United States.

March 8, 2022
·
3 min read
Biotech Beach

Ambrx Biopharma Inc. to Present at Oppenheimer’s 32nd Annual Healthcare Conference

Ambrx Biopharma Inc. to Present at Oppenheimer’s 32nd Annual Healthcare Conference.

March 8, 2022
·
1 min read
Bio NC

TARGET-IBD Study Reveals Nearly a Third of Patients with Inflammatory Bowel Disease Did Not Undergo Objective Assessment Prior to Biologic Dose Change, Discontinuation

A new TARGET-IBD study analysis shows one-third of patients with inflammatory bowel disease (IBD) did not have a record of objective disease activity assessment or therapeutic drug monitoring (TDM) prior to a biologic therapy dose change or discontinuation.

March 8, 2022
·
3 min read
Drug Development

Apex Labs granted phase 2a Clinical Trial Application approval by Health Canada for treatment of PTSD in Veterans

Apex Labs Ltd. (“Apex”, or the “Company”), a socially focused pharmaceutical company, is pleased to announce the receipt of a No Objection Letter (“NOL”) from Health Canada regarding its phase 2a Clinical Trial Application (“CTA”) protocol APEX-002-A01-01 on March 4th, 2022.

March 8, 2022
·
4 min read
Genetown

BION Modernizes Dialysis Technical Operations to Improve Patient Care

BION has reimagined the world of dialysis technical operations, providing efficient, cost effective strategies to maintain dialysis equipment, nationwide.

March 8, 2022
·
3 min read